Home › Precursor T-Cell Lymphoblastic Leukemia-Lymphoma › Tennessee
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma clinical trials in Tennessee
3 studies for Precursor T-Cell Lymphoblastic Leukemia-Lymphoma are looking for participants at sites in Tennessee.
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- TriStar Bone Marrow Transplant / Sarah Cannon Transplant & Cellular Therapy, Nashville
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 2
Ages 1 to 18 · All sexes · Updated Aug 10, 2026 · NCT06390319CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)
- St Jude Children's Research Hospital, Memphis
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Up to age 21 · All sexes · Updated May 19, 2026 · NCT04318678From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.